Inhaled glucocorticoid drugs are more effective than the newer anti-leukotriene tablets for adults with mild or moderate asthma, concludes a study in this week’s BMJ.
Professor Francine Ducharme reviewed 13 trials comparing leukotriene receptor antagonists with low doses of inhaled glucocorticoids for 28 days or more in children and adults.
She found that adults treated with leukotriene receptor antagonists were 60% more likely to suffer worsening of symptoms, whereas those treated with inhaled glucocorticoids experienced fewer night awakenings and fewer days with symptoms.
Risk of side effects was no different between groups, but leukotriene receptor antagonists were associated with a 2.5-fold increase risk of withdrawal because of poor asthma control.
There was insufficient evidence to draw conclusions about effectiveness in children.
Emma Dickinson | Source: alphagalileo
Further information: press.psprings.co.uk/bmj/march/ppr621.pdf
More articles from Health and Medicine:
Immune system activated in schizophrenia
20.11.2009 | Karolinska Institutet
New research helps explain why bird flu has not caused a pandemic
20.11.2009 | Imperial College London
Scientists Unravel Evolution of Highly Toxic Box Jellyfish
20.11.2009 | Life Sciences
When good companies do bad things: Examining illegal corporate behavior
20.11.2009 | Business and Finance
UCR plant scientist's research spawns new discoveries showing how crops survive drought
20.11.2009 | Agricultural and Forestry Science
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News